Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer

被引：1
|
作者：
Zhang, I. [1 ,2 ]
Gilbo, P. [1 ,2 ]
Cox, B. W. [1 ,2 ]
机构：
[1] Northwell Hlth, Dept Radiat Med, Lake Success, NY USA
[2] Hofstra Northwell Sch Med, Hempstead, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1873
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3259
引用
收藏
页码：E530 / E530
页数：1
相关论文
共 50 条
  • [21] Radium-223 in metastatic castration resistant prostate cancer
    Vuong, Winston
    Sartor, Oliver
    Pal, Sumanta K.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 348 - 353
  • [22] The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride
    Randhawa, M.
    Jones, R.
    Stratton, I.
    Bahl, A.
    Bottomley, D.
    Carruthers, H.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (02) : E24 - E24
  • [23] Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer
    Parker, Chris
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 723 - 725
  • [24] Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis
    Zhang, Hanbo
    Graham, Jeffrey
    Czaykowski, Piotr
    Gingerich, Joel Roger
    Bybel, Bohdan
    Dawe, David E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 50 - 50
  • [25] Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and bone metastases
    Exadaktylou, P.
    Paschali, A.
    Panagiotidis, E.
    Papadopoulos, N.
    Kalathas, T.
    Giannoula, E.
    Kotzasarlidou, M.
    Chatzipavlidou, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S569 - S570
  • [26] Initial experience of radium-223 treatment for metastatic castrate resistant prostate cancer in community setting
    Pieczonka, Christopher Michael
    Bienz, Marc Nicolas
    Mouravieva, Vladimira
    Albala, David
    Mouravlev, Vladimir
    Marlados, Nell
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] EARLY EXPERIENCE OF RADIUM-223 TREATMENT FOR METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A PRELIMINARY REPORT
    Bienz, Marc
    Alom, Modar
    Mouravieva, Vladimira
    Zehel, Debby
    Pieczonka, Christopher
    Albala, David
    Williams, Howard
    Mouraviev, Vladimir
    Mariados, Neil
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E806 - E806
  • [28] A phase Ib trial to study the safety and tolerability of atezolizumab with radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Fong, Lawrence
    Morris, Michael
    Armstrong, Andrew
    Petrylak, Daniel
    Vaishampayan, Ulka
    Alva, Ajjai
    Hoffman-Censits, Jean
    Sarkar, Indrani
    Carroll, Susheela
    Schiff, Christina
    Sartor, Oliver
    [J]. CANCER RESEARCH, 2017, 77
  • [29] Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases
    Hague, Christina
    Logue, John P.
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (03) : 175 - 180
  • [30] Real-World Utilization And Outcomes Of Radium-223 In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
    Li, R.
    Dandapani, S. V.
    Amini, A.
    Pal, S. K.
    Dorff, T. B.
    Lyou, Y.
    Vapiwala, N.
    Wong, J. Y. C.
    Glaser, S. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E885 - E886
12345